Health and Healthcare
Johnson & Johnson Raises Forecast on Weaker Dollar
Published:
Last Updated:
Johnson & Johnson (NYSE: JNJ) reported first-quarter 2016 results before markets opened Tuesday. The health care giant reported quarterly adjusted diluted earnings per share (EPS) of $1.68 on revenue of $17.5 billion. In the same period a year ago, it reported EPS of $1.56 on revenue of $17.37 billion. First-quarter results also compare to the consensus estimates for EPS of $1.65 and $17.48 billion in revenue.
On a GAAP, basis the company posted EPS of $1.54, compared with $1.53 in the same period a year ago. Adjustments included after-tax intangible amortization expense of about $200 million and after-tax charge for special items totaling approximately the same amount.
Johnson & Johnson increased its adjusted earnings guidance for 2016 to a new range of $6.53 to $6.68 per share. Revenue guidance was raised to a range of $71.2 billion to $71.9 billion. The company said the new guidance reflects a weaker dollar which should prove a positive impact on revenues and earnings.
The consensus estimate called for full-year EPS of $6.54 on revenue of $71.55 billion. For the second quarter analysts are looking for $1.66 in EPS and revenue of $17.95 billion.
The firm’s CEO said:
Our Pharmaceuticals business continues to deliver impressive levels of growth, we have steady improvement in our Consumer business, and we are seeing momentum in our Medical Devices businesses, all of which are fueling our optimism for the full-year ahead.
Worldwide consumer sales declined by 5.8% year over year to $3.2 billion, including a negative currency impact of 5.6% and a negative operational impact of 0.2%. Pharmaceutical sales rose 5.9% to $8.2 billion on a jump of 12.9% in U.S. sales and a drop of 3.4% in international sales due to a negative currency impact of 6%. Medical devices sales fell 2.4% to $6.1 billion as a result of an operational increase of 0.5% and a negative currency impact of 2.9%.
Shares closed at $110.93 on Monday and were up 0.7% in Tuesday’s premarket trading to $111.83. The stock’s 52-week range is $81.79 to $111.10. The high was posted Monday. Thomson Reuters had a consensus analyst price target of about $111.53 before the results were announced. The dividend yield is 3.0%.
The Average American Has No Idea How Much Money You Can Make Today (Sponsor)
The last few years made people forget how much banks and CD’s can pay. Meanwhile, interest rates have spiked and many can afford to pay you much more, but most are keeping yields low and hoping you won’t notice.
But there is good news. To win qualified customers, some accounts are paying almost 10x the national average! That’s an incredible way to keep your money safe and earn more at the same time. Our top pick for high yield savings accounts includes other benefits as well. You can earn up to 3.80% with a Checking & Savings Account today Sign up and get up to $300 with direct deposit. No account fees. FDIC Insured.
Click here to see how much more you could be earning on your savings today. It takes just a few minutes to open an account to make your money work for you.
Our top pick for high yield savings accounts includes other benefits as well. You can earn up to 4.00% with a Checking & Savings Account from Sofi. Sign up and get up to $300 with direct deposit. No account fees. FDIC Insured.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.